Lawrence Livermore National Laboratory

Lawrence Livermore National Laboratory

home \ about ipo
About IPO

The LLNL Industrial Partnerships Office (IPO), with its staff of scientists, engineers, attorneys, and entrepreneurs, is the conduit through which the Laboratory connects industry partners with Laboratory developed technologies. In addition to technology licenses, work for others agreements and CRADAs, the Laboratory offers several unique partnering arrangements. For example, IPO works with university entrepreneurship centers and business schools, making technologies available for students to use in business plan competitions. IPO also has an "entrepreneurs in readiness" program in which entrepreneurs searching for new opportunities are matched with LLNL technologies ready for commercialization.

IPO currently has active commercial licenses with more than 100 companies as well as dozens of active CRADAs. Licensing and royalty income in recent years has topped $8 million annually representing more than $300 million in annual sales of products based on LLNL technologies. LLNL licensed technologies have enabled the launch of numerous new businesses that are helping drive economic growth locally, regionally and beyond.


IPO in 2012

Invention Disclosures 163
US Patent Application filings
Ordinary filings 61
Continuing filings 29
U.S. Patents issued 78
Foreign Patent Application filings 41
Foreign Patents issued 22
Licenses executed 18
CRADAs executed 4
End user Agreements executed 51
Nondisclosure Agreements executed 453
Licenses under management 108
CRADAs under management 29
Inter-institutional Agreements under management 25
Material Transfer Agreements under management 102
Licensing Revenue $9,649,845
CRADA funding $4,703,823

LLNL-WEB-411851 Privacy & Legal Notice